Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
BRIEF-Denali Therapeutics Q2 Operating Expenses USD 134.145 Million

BRIEF-Denali Therapeutics Q2 Operating Expenses USD 134.145 Million

ReutersReuters2026/08/06 20:02

Aug 06 (Reuters) - Denali Therapeutics Q2 net income USD -127.553 million.

  • Q2 basic EPS USD -0.68
  • Q2 operating income USD -130.541 million
  • Q2 TOTAL REVENUE USD 3.6 MILLION
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!